Profound lymphopenia is associated with a lower risk of hepatic cytolysis during antithymocyte globulin administration.
Am J Hematol. 2016;91(4):E276-8.
MeSH terms: Antilymphocyte Serum; Humans; Immunosuppressive Agents; Incidence; Lymphopenia; Risk Factors; Time Factors
DOI: 10.1002/ajh.24309